CN112300411B - 一种功能化卟啉水凝胶及其制备方法和应用 - Google Patents
一种功能化卟啉水凝胶及其制备方法和应用 Download PDFInfo
- Publication number
- CN112300411B CN112300411B CN202011285411.1A CN202011285411A CN112300411B CN 112300411 B CN112300411 B CN 112300411B CN 202011285411 A CN202011285411 A CN 202011285411A CN 112300411 B CN112300411 B CN 112300411B
- Authority
- CN
- China
- Prior art keywords
- hydrogel
- metalloporphyrin
- photosensitizer
- functional monomer
- functionalized porphyrin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 47
- 150000004032 porphyrins Chemical class 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000000178 monomer Substances 0.000 claims abstract description 34
- 239000003504 photosensitizing agent Substances 0.000 claims abstract description 23
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 14
- 239000011259 mixed solution Substances 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000006243 chemical reaction Methods 0.000 claims abstract description 7
- 230000001699 photocatalysis Effects 0.000 claims abstract description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000001914 filtration Methods 0.000 claims abstract description 6
- 239000003999 initiator Substances 0.000 claims abstract description 6
- 239000001301 oxygen Substances 0.000 claims abstract description 6
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 6
- 238000007146 photocatalysis Methods 0.000 claims abstract description 6
- 238000007789 sealing Methods 0.000 claims abstract description 6
- 238000002791 soaking Methods 0.000 claims abstract description 6
- 238000005406 washing Methods 0.000 claims abstract description 6
- -1 nitrogen heterocyclic ring alkene Chemical class 0.000 claims abstract description 4
- 238000003756 stirring Methods 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 12
- KFDVPJUYSDEJTH-UHFFFAOYSA-N 4-ethenylpyridine Chemical group C=CC1=CC=NC=C1 KFDVPJUYSDEJTH-UHFFFAOYSA-N 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- 229920002554 vinyl polymer Polymers 0.000 claims description 5
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 2
- 230000002378 acidificating effect Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 238000002428 photodynamic therapy Methods 0.000 abstract description 5
- 238000001035 drying Methods 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 4
- 238000007710 freezing Methods 0.000 abstract description 4
- 230000008014 freezing Effects 0.000 abstract description 4
- 239000003929 acidic solution Substances 0.000 abstract 1
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium peroxydisulfate Substances [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 8
- VAZSKTXWXKYQJF-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)OOS([O-])=O VAZSKTXWXKYQJF-UHFFFAOYSA-N 0.000 description 8
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 4
- 239000003431 cross linking reagent Substances 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 238000010526 radical polymerization reaction Methods 0.000 description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 238000002211 ultraviolet spectrum Methods 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 239000011837 N,N-methylenebisacrylamide Substances 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- KIQQAJNFBLKFPO-UHFFFAOYSA-N magnesium;porphyrin-22,23-diide Chemical compound [Mg+2].[N-]1C(C=C2[N-]C(=CC3=NC(=C4)C=C3)C=C2)=CC=C1C=C1C=CC4=N1 KIQQAJNFBLKFPO-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000002165 photosensitisation Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/18—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
- B01J31/1805—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing nitrogen
- B01J31/181—Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine
- B01J31/1825—Ligands comprising condensed ring systems, e.g. acridine, carbazole
- B01J31/183—Ligands comprising condensed ring systems, e.g. acridine, carbazole with more than one complexing nitrogen atom, e.g. phenanthroline
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J35/00—Catalysts, in general, characterised by their form or physical properties
- B01J35/20—Catalysts, in general, characterised by their form or physical properties characterised by their non-solid state
- B01J35/23—Catalysts, in general, characterised by their form or physical properties characterised by their non-solid state in a colloidal state
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J35/00—Catalysts, in general, characterised by their form or physical properties
- B01J35/30—Catalysts, in general, characterised by their form or physical properties characterised by their physical properties
- B01J35/39—Photocatalytic properties
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/52—Amides or imides
- C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
- C08F220/56—Acrylamide; Methacrylamide
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F226/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
- C08F226/06—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a heterocyclic ring containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F226/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
- C08F226/06—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a heterocyclic ring containing nitrogen
- C08F226/10—N-Vinyl-pyrrolidone
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/02—Compositional aspects of complexes used, e.g. polynuclearity
- B01J2531/0238—Complexes comprising multidentate ligands, i.e. more than 2 ionic or coordinative bonds from the central metal to the ligand, the latter having at least two donor atoms, e.g. N, O, S, P
- B01J2531/0241—Rigid ligands, e.g. extended sp2-carbon frameworks or geminal di- or trisubstitution
- B01J2531/025—Ligands with a porphyrin ring system or analogues thereof, e.g. phthalocyanines, corroles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/20—Complexes comprising metals of Group II (IIA or IIB) as the central metal
- B01J2531/26—Zinc
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2333/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
- C08J2333/24—Homopolymers or copolymers of amides or imides
- C08J2333/26—Homopolymers or copolymers of acrylamide or methacrylamide
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2339/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Derivatives of such polymers
- C08J2339/04—Homopolymers or copolymers of monomers containing heterocyclic rings having nitrogen as ring member
- C08J2339/06—Homopolymers or copolymers of N-vinyl-pyrrolidones
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2339/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Derivatives of such polymers
- C08J2339/04—Homopolymers or copolymers of monomers containing heterocyclic rings having nitrogen as ring member
- C08J2339/08—Homopolymers or copolymers of vinyl-pyridine
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/0091—Complexes with metal-heteroatom-bonds
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Abstract
本发明提出了一种功能化卟啉水凝胶及其制备方法和应用,制备方法包括以下步骤:(1)室温下,将功能单体溶解在pH=2.0的酸性溶液中,然后加入MBA和光敏剂金属卟啉,得到混合溶液,所述功能单体包括含氮杂环的烯类单体和丙烯酰胺;(2)混合溶液在室温下磁力搅拌,且通入氮气以排除体系内的氧气,然后加入引发剂APS,密封,在50‑80℃的恒温水浴下反应6‑10小时;(3)将步骤(2)反应得到的产物洗涤、浸泡和过滤,重复多次,低温冷冻干燥。本发明通过配合作用负载光敏剂金属卟啉,使得光敏剂金属卟啉可以在水凝胶中稳定存在,有效提高了金属卟啉的稳定性,而且制备方法简单、易于操作,易于推广应用,可广泛应用在光光动力学疗法和光催化等领域中。
Description
技术领域
本发明涉及生物与纳米材料技术领域领域,特别是指一种功能化卟啉水凝胶及其制备方法和应用。
背景技术
金属卟啉类化合物广泛存在于自然环境和生命体中,例如叶绿素的核心是镁卟啉,血红蛋白的核心是铁卟啉化合物。大部分金属卟啉都具有疏水性质,使其在水溶液中很难稳定存在,而光动力学疗法和光催化领域大部分都在水溶液中进行。而水溶性金属卟啉,由于其自身结构特点,在光照下容易分解失去活性,限制了其进一步的应用。而且,卟啉作为光敏剂在光动力学疗法中必须在肿瘤部位富集才能发挥作用,单独的金属卟啉很难到达肿瘤部位。因此,必须将金属卟啉负载到纳米材料中。
另外一面,水凝胶以其独特三维网状的结构特点,作为药物载体具有很大的优势。首先,水凝胶可以实现对光敏剂的负载,将其包载到凝胶内部有效防止光敏剂的释放,减少光敏剂对正常的组织得聚集,减少对正常器官的伤害。其次,水凝胶还可以负载多种类型的光敏剂和染料分子,扩大材料的吸光范围,协同作用,具有较高的光催化效率,实现更好的治疗效果。最后,水凝胶材料可以有效到达肿瘤部位,利用肿瘤部位的高通透性和EPR效应,将其靶向到达肿瘤区域。
水凝胶对金属卟啉的负载主要通过共价键和非共价键作用力两种方式。非共价键作用的组装以其简单高效的制备方法受到人们广泛的关注。但以这种方式的负载由于静电相互作用力比较弱,存在光敏剂从水凝胶释放的问题,从而降低了其光敏效率。
发明内容
本发明提出一种功能化卟啉水凝胶及其制备方法和应用,通过配合作用负载光敏剂金属卟啉,使得光敏剂金属卟啉可以在水凝胶中稳定存在,有效提高了金属卟啉的稳定性,而且制备方法简单、易于操作,易于推广应用,可广泛应用在光光动力学疗法和光催化等领域中。
本发明的技术方案是这样实现的:一种功能化卟啉水凝胶的制备方法,包括以下步骤:
(1)室温下,将功能单体溶解在pH=2.0的酸性溶液中,然后加入N,N-亚甲基双丙烯酰胺 (MBA )和光敏剂金属卟啉,得到混合溶液,所述功能单体包括含氮杂环的烯类单体和丙烯酰胺,含氮杂环的烯类单体和丙烯酰胺的摩尔比为1:1-9,MBA加入量为功能单体质量的0.5-5%;
(2)步骤(1)中的混合溶液在室温下磁力搅拌,且通入氮气以排除体系内的氧气,然后加入引发剂过硫酸铵(APS),APS加入量为功能单体质量的0.5-3%,密封,在50-80℃的恒温水浴下反应6-10小时;
(3)将步骤(2)反应得到的产物洗涤、浸泡和过滤,重复多次,低温冷冻干燥,得到功能化卟啉水凝胶。
优选地,步骤(1)中,含氮杂环的烯类单体和丙烯酰胺的摩尔比1:1。
优选地,步骤(1)中,含氮杂环的烯类单体包括4-乙烯基吡啶或乙烯基吡咯烷酮。
优选地,步骤(1)中,光敏剂金属卟啉与功能单体的摩尔比为0.1-1:100。
优选地,步骤(1)中,光敏剂金属卟啉为5,10,15,20-四-(4-对磺酸基苯基)-锌卟啉(ZnTPPS)。
优选地,步骤(1)中,MBA的加入量为功能单体质量的5%。
优选地,步骤(2)中,APS加入量为功能单体质量的1%,密封,在60℃的恒温水浴下反应8小时。
一种功能化卟啉水凝胶,采用上述方法制备。
所述功能化卟啉水凝胶在光动力学疗法和光催化中的应用。
本发明的有益效果:
(1)本发明通过吡啶或者吡咯烷酮上的N与金属卟啉之间很强的配位作用,水凝胶可以高效负载光敏剂金属卟啉,使其具有较强产生单线态氧的能力,也解决了一般光敏剂从载体中容易释放的问题,有利于提高材料的稳定性,与静电作用对金属卟啉进行负载相比,配位作用具有更强的作用力和对金属卟啉更为高效的负载。
(2)本发明制备功能化卟啉水凝胶的方法简单、易于操作,成本低,而且在水凝胶交联过程中,直接把金属卟啉负载在水凝胶中,更有利于提高光敏剂的负载效率以及稳定性。水凝胶的三维网络结构在药物载体方面具有很大优势,可以负载多种金属卟啉和色素分子,使其在光催化和光化学等领域有着广阔的应用前景。
附图说明
为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。
图1为实施例一功能化卟啉水凝胶的扫描电镜照片;
图2为实施例一功能化水凝胶催化降解ABDA的紫外光谱随时间变化曲线。
具体实施方式
下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有付出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例一
一种功能化卟啉水凝胶的制备方法,包括以下步骤:
(1)采用自由基聚合方法,将4-乙烯基吡啶和丙烯酰胺(摩尔比为1:1)为功能单体溶解于pH=2.0的盐酸水溶液中,MBA 为交联剂、同时加入金属卟啉ZnTPPS,得到混合溶液,其中,MBA的加入量为功能单体质量的5%,ZnTPPS加入量为与功能单体摩尔比1:100;
(2)将步骤(1)中的混合溶液在室温下磁力搅拌30分钟,通入氮气3分钟以排除体系内的氧气。然后加入引发剂APS,加入量为功能单体质量的1%,密封,在60℃的恒温水浴下反应8小时;
(3)将步骤(2)反应得到的产物以去离子水进行洗涤,浸泡和过滤,重复6次,以除尽非水凝胶的成分,最后将产物低温冷冻干燥,得到水凝胶材料。
为了验证水凝胶形成,对制备出的水凝胶做了扫描电镜的表征,如图1所示。通过图1可以看到,制备出的水凝胶具有三维网状结构。
实施例二
本实施例与实施例一基本相同,不同之处在于:步骤1中,将4-乙烯基吡啶改为乙烯基吡咯烷酮。
为了验证水凝胶是否具有产生单线态氧的能力,用9,10-蒽基-双(亚甲基)二丙二酸(ABDA)作为单线态氧的捕捉剂。将水凝胶放入的ABDA溶液中,然后用氙灯光源下照射,其紫外光谱随时间的变化曲线如图2所示。可以看到,380nm处以及401nm处的ABDA特征吸收峰有下降趋势,随着光照时间的延长,产生单线态氧越来越多,ABDA特征吸收峰下降越明显,从而证明了水凝胶具有产生单线态的能力。
实施例三
一种功能化卟啉水凝胶的制备方法,包括以下步骤:
(1)采用自由基聚合方法,将4-乙烯基吡啶和丙烯酰胺(摩尔比为1:5)为功能单体溶解于pH=2.0的盐酸水溶液中,MBA 为交联剂、同时加入金属卟啉ZnTPPS,得到混合溶液,其中,MBA的加入量为功能单体质量的0.5%,ZnTPPS加入量为与功能单体摩尔比0.1:100;
(2)将步骤(1)中的混合溶液在室温下磁力搅拌30分钟,通入氮气3分钟以排除体系内的氧气。然后加入引发剂APS,加入量为功能单体质量的0.5%,密封,在50℃的恒温水浴下反应10小时;
(3)将步骤(2)反应得到的产物以去离子水进行洗涤,浸泡和过滤,重复6次,以除尽非水凝胶的成分,最后将产物低温冷冻干燥,得到水凝胶材料。
实施例四
一种功能化卟啉水凝胶的制备方法,包括以下步骤:
(1)采用自由基聚合方法,将4-乙烯基吡啶和丙烯酰胺(摩尔比为1:9)为功能单体溶解于pH=2.0的盐酸水溶液中,MBA 为交联剂、同时加入金属卟啉ZnTPPS,得到混合溶液,其中,MBA的加入量为功能单体质量的3.5%,ZnTPPS加入量为与功能单体摩尔比0.5:100;
(2)将步骤(1)中的混合溶液在室温下磁力搅拌30分钟,通入氮气3分钟以排除体系内的氧气。然后加入引发剂APS,加入量为功能单体质量的1.5%,密封,在80℃的恒温水浴下反应6小时;
(3)将步骤(2)反应得到的产物以去离子水进行洗涤,浸泡和过滤,重复6次,以除尽非水凝胶的成分,最后将产物低温冷冻干燥,得到水凝胶材料。
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (8)
1.一种功能化卟啉水凝胶的制备方法,其特征在于,包括以下步骤:
(1)室温下,将功能单体溶解在pH=2.0的酸性水溶液中,然后加入MBA和光敏剂金属卟啉,得到混合溶液,所述功能单体为含氮杂环的烯类单体和丙烯酰胺,含氮杂环的烯类单体和丙烯酰胺的摩尔比为1:1-9,MBA加入量为功能单体质量的0.5-5%,光敏剂金属卟啉为ZnTPPS;
(2)步骤(1)中的混合溶液在室温下磁力搅拌,且通入氮气以排除体系内的氧气,然后加入引发剂APS,APS加入量为功能单体质量的0.5-3%,密封,在50-80℃的恒温水浴下反应6-10小时;
(3)将步骤(2)反应得到的产物洗涤、浸泡和过滤,重复多次,低温冷冻干燥,得到功能化卟啉水凝胶。
2.根据权利要求1所述的一种功能化卟啉水凝胶的制备方法,其特征在于,步骤(1)中,含氮杂环的烯类单体和丙烯酰胺的摩尔比1:1。
3.根据权利要求1或2所述的一种功能化卟啉水凝胶的制备方法,其特征在于,步骤(1)中,含氮杂环的烯类单体为4-乙烯基吡啶或乙烯基吡咯烷酮。
4.根据权利要求1所述的一种功能化卟啉水凝胶的制备方法,其特征在于,步骤(1)中,光敏剂金属卟啉与功能单体的摩尔比为0.1-1:100。
5.根据权利要求1所述的一种功能化卟啉水凝胶的制备方法,其特征在于,步骤(1)中,MBA的加入量为功能单体质量的5%。
6.根据权利要求1所述的一种功能化卟啉水凝胶的制备方法,其特征在于,步骤(2)中,APS加入量为功能单体质量的1%,密封,在60℃的恒温水浴下反应8小时。
7.一种采用权利要求1-6之一所述方法制备的功能化卟啉水凝胶。
8.一种权利要求7所述的功能化卟啉水凝胶在光催化中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011285411.1A CN112300411B (zh) | 2020-11-17 | 2020-11-17 | 一种功能化卟啉水凝胶及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011285411.1A CN112300411B (zh) | 2020-11-17 | 2020-11-17 | 一种功能化卟啉水凝胶及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112300411A CN112300411A (zh) | 2021-02-02 |
CN112300411B true CN112300411B (zh) | 2022-09-16 |
Family
ID=74334857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011285411.1A Active CN112300411B (zh) | 2020-11-17 | 2020-11-17 | 一种功能化卟啉水凝胶及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112300411B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105732919A (zh) * | 2016-03-25 | 2016-07-06 | 同济大学 | 一种含卟啉的温度及多种金属离子双重响应性嵌段共聚物凝胶的制备方法 |
CN107615062A (zh) * | 2015-02-09 | 2018-01-19 | 弹弓生物科学公司 | 具有可调光学性质的水凝胶颗粒以及使用其的方法 |
CN109575912A (zh) * | 2018-11-26 | 2019-04-05 | 西北师范大学 | 一种增强四羧基苯基卟啉电化学发光强度的方法 |
-
2020
- 2020-11-17 CN CN202011285411.1A patent/CN112300411B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107615062A (zh) * | 2015-02-09 | 2018-01-19 | 弹弓生物科学公司 | 具有可调光学性质的水凝胶颗粒以及使用其的方法 |
CN105732919A (zh) * | 2016-03-25 | 2016-07-06 | 同济大学 | 一种含卟啉的温度及多种金属离子双重响应性嵌段共聚物凝胶的制备方法 |
CN109575912A (zh) * | 2018-11-26 | 2019-04-05 | 西北师范大学 | 一种增强四羧基苯基卟啉电化学发光强度的方法 |
Non-Patent Citations (1)
Title |
---|
非共价作用对金属卟啉光学稳定性的影响;柴志华等;《华北科技学院学报》;20151215;第12卷(第6期);第109-113页 * |
Also Published As
Publication number | Publication date |
---|---|
CN112300411A (zh) | 2021-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mondal et al. | Porphyrins and phthalocyanines: promising molecules for light-triggered antibacterial nanoparticles | |
Sadrearhami et al. | Biofilm dispersal using nitric oxide loaded nanoparticles fabricated by photo-PISA: influence of morphology | |
CN107551275B (zh) | 一种磁性纳米药物载体的制备及其负载盐酸阿霉素的方法 | |
CN113941009B (zh) | 一种金属有机骨架纳米载体及其制备方法与应用 | |
Li et al. | Metalloporphyrin-bound Janus nanocomposites with dual stimuli responsiveness for nanocatalysis in living radical polymerization | |
CN112225893B (zh) | 一种基于卟啉和海因的多孔有机聚合物及其制备方法和应用 | |
Huang et al. | Dendritic organosilica nanospheres with large mesopores as multi-guests vehicle for photoacoustic/ultrasound imaging-guided photodynamic therapy | |
Singh et al. | CuAAC ensembled 1, 2, 3-triazole linked nanogels for targeted drug delivery: A review | |
CN113368077B (zh) | 一种聚多巴胺修饰的纳米共价有机框架及其制备方法与应用 | |
CN112300411B (zh) | 一种功能化卟啉水凝胶及其制备方法和应用 | |
Ma et al. | O2 self-sufficient and glutathione-depleted nanoplatform for amplifying phototherapy synergistic thermodynamic therapy | |
Liu et al. | Polymer-coated calcium peroxide nanoparticles as an oxygen self-supplying platform for enhanced photodynamic therapy | |
CN101157744A (zh) | 一种金属材料表面接枝聚合物的方法 | |
CN114015437B (zh) | 一种红光碳量子点及其制备方法 | |
CN107670039B (zh) | 一种过氧化氢酶与光敏分子复合物及其制备方法和应用 | |
Roveda et al. | Light-triggered and cysteine-mediated nitric oxide release from a biodegradable starch-based film | |
Chen et al. | 2-Mercaptoimidazole selectively etching and thiol-functionalized ZIF-8 metal–organic framework to serve as a multifaceted platform for radical scavenging and Au loading | |
CN113101365A (zh) | 一种具有线粒体靶向特性的光动力纳米平台及其制备方法和应用 | |
Castellanos et al. | Development of plasmonic Chitosan–Squarate hydrogels via bioinspired nanoparticle growth | |
Ton et al. | Hematin-conjugated gelatin as an effective catalyst for preparing biological hydrogels | |
CN114642727B (zh) | 一种光动力治疗纳米平台及其制备方法与应用 | |
Arif et al. | Crosslinked polymeric networks of TiO 2–polymer composites: a comprehensive review | |
CN114601936A (zh) | 一种靶向肿瘤的近红外光响应的一氧化氮纳米产生器、制备方法及其应用 | |
Maddahzadeh-Darini et al. | A smart hydrogel carrier for silver nanoparticles: an improved recyclable catalyst with temperature-tuneable catalytic activity for alcohol and olefin oxidation | |
Li et al. | Metalloporphyrin-Based Biomimetic Catalysis: Applications, Modifications and Flexible Microenvironment Influences (A Review) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |